Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Balemans

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cell Death and Differentiation|July 1, 1996
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCRI Herr, L Balemans, T Böhler, et al.
In Vivo (Athens, Greece)|November 1, 1991
Effective immunotherapy with local low doses of interleukin-2W Den Otter, R A Maas, J W Koten, et al.
Hepato-Gastroenterology|August 3, 1999
Local low-dose IL-2 therapyW Den Otter, L Balemans, J J Battermann, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cell Death and Differentiation|July 1, 1996
Monitoring of CD95 (APO-1/Fas) ligand expression in human T cells by quantitative RT-PCRI Herr, L Balemans, T Böhler, et al.
In Vivo (Athens, Greece)|November 1, 1991
Effective immunotherapy with local low doses of interleukin-2W Den Otter, R A Maas, J W Koten, et al.
Hepato-Gastroenterology|August 3, 1999
Local low-dose IL-2 therapyW Den Otter, L Balemans, J J Battermann, et al.
Pageof 1